Abstract: Dr. Gisele Werneck — MAAFIM 6th International Conference 2026

Presentation Abstract

Hormonal Optimization for Brain Health: From Childhood Neurodevelopment to Cognitive Longevity

Day 2 · 21st August 2026 · 11:45 AM

Background & Clinical Gap

Hormones regulate every aspect of brain function — synaptic pruning in childhood, mood stability in adulthood, and neuroprotection in aging. Yet conventional “normal range” testing misses the clinically relevant question: What level optimizes brain function for this individual?

What This Session Delivers

A practical framework for assessing and optimizing four hormonal axes with direct brain impact, using circadian-sensitive testing and function-guided targets.

Key Clinical Insights

  • Thyroid: T3 is the brain’s hormone. Low T3 with normal TSH (euthyroid sick syndrome / low T3 syndrome) is a signature of inflammatory-metabolic stress — not central hypothyroidism. Selenium, zinc, and adequate carbohydrates (for T4→T3 conversion) matter more than levothyroxine in these cases.
  • Cortisol: The circadian slope matters more than the number. A flattened diurnal curve (high midnight cortisol, blunted morning peak) predicts hippocampal atrophy. A globally low curve (low all day) suggests HPA exhaustion. Treatment differs completely.
  • Insulin: Central resistance drives anhedonia and brain fog. Peripheral insulin resistance correlates with but does not equal brain insulin resistance. Intranasal insulin (investigational) and time-restricted eating directly target CNS insulin signaling.
  • Neurosteroids: The missing piece in “hormone replacement.” Allopregnanolone (GABA-A PAM), pregnenolone, and DHEA decline with age and chronic stress — often independent of circulating estradiol or testosterone. Low allopregnanolone is linked to PMS, perimenopausal depression, and postpartum mood disorders.

Practical Assessment Protocol (What You Can Do)

  • TSH, free T3, free T4, reverse T3. Optimal (brain) vs. Normal: fT3 in upper half of range; rT3 <12 ng/dL.
  • Salivary x4 (waking, noon, sunset, bedtime). Optimal (brain) vs. Normal: Slope >40% drop by noon; midnight <50% of morning.
  • Fasting insulin + HOMA-IR. Optimal (brain) vs. Normal: Insulin <8 μIU/mL; HOMA-IR <1.5.
  • Pregnenolone, DHEA-S, allopregnanolone (specialty lab). Optimal (brain) vs. Normal: Pregnenolone 50–100 ng/dL (age-dependent).

Intervention Ladder (Least to Most Intensive)

  • Lifestyle: Circadian light exposure, sleep timing, meal timing
  • Nutraceutical: Magnesium glycinate, zinc, selenium, vitamin D, phosphatidylserine (for cortisol modulation)
  • Botanical: Ashwagandha (low cortisol), Rhodiola (fatigue), Bacopa (cognition)
  • Hormonal (when indicated): Pregnenolone (microdose 5–10 mg sublingual), DHEA (5–15 mg, monitor DHEA-S), bioidentical T3 (rare, case-specific)

Learning Objectives

  • Implement circadian-sensitive hormonal testing (cortisol x4, fasting morning T3/rT3, insulin).
  • Distinguish low T3 syndrome from central hypothyroidism — treat differently.
  • Recognize neurosteroid deficiency (allopregnanolone, pregnenolone) in mood disorders across female reproductive stages.
  • Build a stepped care algorithm from lifestyle → nutraceutical → hormonal interventions.
Return to Schedule